US Capitol Capsule: Calls grow for strong IP in TPP, as political battles mount
This article was originally published in Scrip
While the contrasts between the Obama and Romney Medicare plans are destined to remain atop the issues in the race for the White House, there's a push to get the debate back on track for big ideas to drive economic growth, with some fearing efforts to seal the deal for the Trans-Pacific Partnership (TPP) could become a casualty of the deepening polarized political climate – in the US and abroad (scripintelligence, 13 August 2012).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.